Results 181 to 190 of about 147,982 (313)

A Photothermal Transducer Regulates Transmembrane Calcium Flow for Synergistic Osteoarthritis Therapy. [PDF]

Adv Sci (Weinh)
Yu C, Liu Y, Kang K, Yu J, Xia X, Deng Y, Lu Y, Yang H, Li L, Xu W, Zhang Y, Zhu X.   +11 more
europepmc   +1 more source

Exploring Green Entrepreneurship: Clarifying Conceptual Overlaps and Distinctions With Sustainability‐Related Entrepreneurship

Business Strategy and the Environment, EarlyView.
ABSTRACT Increasing global emphasis on sustainability has positioned green entrepreneurship as a key mechanism for aligning business with environmental responsibility. Despite growing research, green entrepreneurship remains conceptually fragmented, with overlapping constructs and inconsistent definitions, which may have constrained theoretical and ...
Alexandra Elena Carst, Jin‐ichiro Yamada   +1 more
wiley   +1 more source

Engineered MoS₂ Nanoplatforms for Drug-Enhanced Cancer Phototherapy: From Design Strategies to Translational Opportunities. [PDF]

Nanomaterials (Basel)
Tavares C, Dias MC, Freitas B, Magalhães FD, Pinto AM.   +4 more
europepmc   +1 more source

Eco‐Innovation Among Environmental Small and Medium Enterprises: A Complexity Theory View on a Regional Paradox

Business Strategy and the Environment, EarlyView.
ABSTRACT Environmental entrepreneurship and eco‐innovation, although cornerstones in the transition to a sustainable world, form a research nexus that remains largely understudied. We draw on the theory of complexity and the notion of cultural, temporal, and relational complexities to explain the process of eco‐innovation among environmental small ...
Georgios Outsios, Stefan Chichevaliev
wiley   +1 more source

The Heterogeneous Impact of Non‐Financial Reporting Directive Legal Implementation on ESG Performance in EU‐Listed Companies

Business Strategy and the Environment, EarlyView.
ABSTRACT This study examines the impact of EU Directive 2014/95/EU (NFRD) on the Environmental, Social and Governance (ESG) performance of EU‐listed companies, focusing on variations across ESG dimensions and national institutional contexts. Using a dataset of 19,036 observations from 2010 to 2022, we apply a time‐varying Difference‐in‐Differences ...
Yuqing Xiao, Antonio Somoza
wiley   +1 more source

The silent warning: High-sensitivity cardiac troponin as a biomarker for subclinical coronary artery disease in seemingly healthy Japanese population. [PDF]

Prev Med Rep
Suganuma R, Shimada T, Sonoda A, Murakoshi D, Hiramatsu N, Sabashi T, Koga S.   +6 more
europepmc   +1 more source

Management of severe bone loss in patients at risk of medication‐related osteonecrosis of the jaw with microsurgery and guided bone regeneration: A case study

Clinical Advances in Periodontics, EarlyView.
Abstract Background Medication‐related osteonecrosis of the jaw (MRONJ) is a challenging complication associated with antiresorptive medications. Its exact pathophysiology remains unclear, but dental extractions and infections are known triggers, complicating prevention, and treatment.
Pedro Franco Ferreira, José Maurício Paradella de Camargo, Lara Maria Alencar Ramos Innocentini, Ana Carolina Fragoso Motta   +3 more
wiley   +1 more source

(808) Merxia [PDF]

, 2003
openaire   +1 more source

Targetable Biomimetic NIR-II Theranostic Nanoplatform for Highly Efficient Multimodal Imaging-Guided Photothermal Therapy of Cervical Cancer. [PDF]

Int J Nanomedicine
Chu C, Du Z, Wang J, Aili M, Li J, Xiong J, Ma R, Ma C, Alifu N.   +8 more
europepmc   +1 more source

Health economic considerations for pharmacogenomic services in the United Kingdom: The Centre for Excellence in Regulatory Science and Innovation in Pharmacogenomics

British Journal of Clinical Pharmacology, EarlyView.
Dyfrig A. Hughes, Henry Fong, Grace Hampson, Catrin O. Plumpton, Chris Sampson   +4 more
wiley   +1 more source